Robot-assisted brain surgery tested for rare stroke risk disease
NCT ID NCT07140731
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new robotic surgical system (Symani) in 15 adults with Moyamoya disease, a rare condition that narrows brain arteries and raises stroke risk. The surgery aims to improve blood flow to the brain. Participants must have mild to moderate symptoms and agree to the procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MOYAMOYA DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jacobs Institute
RECRUITINGBuffalo, New York, 14203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily pill and a simple physical therapy delay moyamoya strokes?
- Metaverse meets microsurgery: XR platform aims to sharpen brain bypass precision
- French biobank aims to unlock secrets of rare brain vessel diseases
- Your digital twin could help prevent another stroke
- Could a simple MRI and blood test predict moyamoya before it strikes?
- Massive study aims to predict brain surgery success